Robert T. Abraham

Active 1975–2025

117
Papers
36,870
Citations
94
h-index
117
i10-index

Citations

Citations per year for Robert T. Abraham1966: 2 citations1975: 1 citations1976: 2 citations1977: 2 citations1978: 1 citations1979: 1 citations1980: 1 citations1982: 1 citations1987: 1 citations1988: 4 citations1989: 12 citations1990: 18 citations1991: 21 citations1992: 45 citations1993: 72 citations1994: 86 citations1995: 114 citations1996: 109 citations1997: 169 citations1998: 206 citations1999: 259 citations2000: 306 citations2001: 454 citations2002: 463 citations2003: 522 citations2004: 679 citations2005: 523 citations2006: 483 citations2007: 427 citations2008: 375 citations2009: 420 citations2010: 424 citations2011: 443 citations2012: 372 citations2013: 481 citations2014: 506 citations2015: 446 citations2016: 335 citations2017: 341 citations2018: 238 citations2019: 942 citations2020: 900 citations2021: 944 citations2022: 550 citations2023: 450 citations2024: 626 citations2025: 304 citations2026: 9 citations1967–1974: no citations, so these years are not shown1981: no citations, so this year is not shown1983–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,742 citing papers, 35% of this breakdownChina: 1,929 citing papers, 11.8% of this breakdownUnited Kingdom: 1,107 citing papers, 6.7% of this breakdownGermany: 767 citing papers, 4.7% of this breakdownCanada: 636 citing papers, 3.9% of this breakdownFrance: 579 citing papers, 3.5% of this breakdownItaly: 571 citing papers, 3.5% of this breakdownJapan: 546 citing papers, 3.3% of this breakdownSwitzerland: 362 citing papers, 2.2% of this breakdownSpain: 333 citing papers, 2% of this breakdownAustralia: 302 citing papers, 1.8% of this breakdownIndia: 263 citing papers, 1.6% of this breakdown
0%35%Other 20%

Fields

  • Biochemistry, Genetics and Molecular Biology50.5%
  • Medicine35.7%
  • Immunology and Microbiology8.2%
  • Neuroscience1.9%
  • Agricultural and Biological Sciences0.9%
  • Chemistry0.8%
  • Other2%

Topics

  • PI3K/AKT/mTOR signaling in cancer5.6%
  • Autophagy in Disease and Therapy5%
  • DNA Repair Mechanisms4%
  • Cancer-related Molecular Pathways3.3%
  • Cancer, Hypoxia, and Metabolism2.3%
  • Immune Cell Function and Interaction2.2%
  • Other77.6%

Coauthors

All papers

Open in search
  1. The PI3K Pathway in Human Disease

    Authors: , , , , , - Cell 2017 cited by 2,764

  2. Guidelines for the use and interpretation of assays for monitoring autophagy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David K. Ann, Shailendra Anoopkumar‐Dukie, Hiroshi Aoki, Nadezda Apostolova, Giuseppe Arancia, John P. Aris, Katsuhiko Asanuma, Nana Asare, Hisashi Ashida, Valerie Askanas, David S. Askew, Patrick Auberger, Misuzu Baba, Steven K. Backues, Eric H. Baehrecke, Ben A. Bahr, Xue-Yuan Bai, Yannick Bailly, Robert A. Baiocchi, Giulia Baldini, Walter Balduini, Andrea Ballabio, Bruce A. Bamber, Edward T. W. Bampton, Gábor Juhász, Clinton R. Bartholomew, Diane C. Bassham, Robert C. Bast, Henri Batoko, Boon-Huat Bay, Isabelle Beau, Daniel M. Béchet, Thomas J. Begley, Christian Behl, Christian Behrends, Soumeya Bekri, Bryan H. Bellaire, Linda J. Bendall, Luca Benetti, Laura Berliocchi, Henri Bernardi, Francesca Bernassola, Sébastien Besteiro, Ingrid Bhatia-Kissova, Xiaoning Bi, Martine Biard-Piechaczyk, Janice S. Blum, Lawrence Boise, Paolo Bonaldo, David L. Boone, Beat Bornhäuser, Karina Ramalho Bortoluci, Ioannis Bossis, Frédéric Bost, Jean‐Pierre Bourquin, Patricia Boya, Michaël Boyer‐Guittaut, Peter V. Bozhkov, Nathan Brady, Claudio Brancolini, Andreas Brech, Jay E. Brenman, Ana Brennand, Emery Bresnick, Patrick Brest, Dave Bridges, Molly L. Bristol, Paul S. Brookes, Eric J. Brown, John H. Brumell and 1,170 more - Autophagy 2012 cited by 4,046

  3. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism

    Authors: , , , , , , , - Genes & Development 1999 cited by 1,336

  4. Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Marc Plancher, Isabel Cuartas, Joan Seoane, Laurence E. Burgess, Robert T. Abraham, David S. Weinstein, Gabriel M. Simon, Matthew P. Patricelli, Todd M. Kinsella - Nature 2024 cited by 102

  5. Cystine–glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 171

  6. Molecular Pathways: Targeting the Cyclin D–CDK4/6 Axis for Cancer Treatment

    Authors: , , , - Clinical Cancer Research 2015 cited by 401

  7. Jurkat T cells and development of the T-cell receptor signalling paradigm

    Authors: , - Nature reviews. Immunology 2004 cited by 604

  8. Ammonia Derived from Glutaminolysis Is a Diffusible Regulator of Autophagy

    Authors: , , , , - Science Signaling 2010 cited by 343

  9. Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin

    Authors: , , , , , , , - Molecular and Cellular Biology 2002 cited by 1,179

  10. Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

    Authors: , , , , , , - Journal of Biological Chemistry 1995 cited by 876

  11. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy

    Authors: , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 224

  12. Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase

    Authors: , , , , , , , , , - Cell Reports 2017 cited by 162

  13. Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 IsMediated by p70S6 Kinase

    Authors: , - Journal of Biological Chemistry 2005 cited by 558

  14. Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor

    Authors: , , , , , , , , , , , , , , , , - Journal of Medicinal Chemistry 2010 cited by 212

  15. Cell cycle checkpoint signaling through the ATM and ATR kinases

    Authors: - Genes & Development 2001 cited by 1,964

  16. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.

    Authors: , , , , , , , , , - 1994 cited by 691

  17. A role for ATR in the DNA damage-induced phosphorylation of p53

    Authors: , , , , , , , , - Genes & Development 1999 cited by 1,052

  18. Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin

    Authors: , , , , , , , - Science 1997 cited by 962

  19. Direct control of CAR T cells through small molecule-regulated antibodies

    Authors: , , , , , , , , , , , , , , - Nature Communications 2021 cited by 50

  20. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.

    Authors: , , , , , , - 2000 cited by 716

  21. Functional Analysis of Human Microtubule-based Motor Proteins, the Kinesins and Dyneins, in Mitosis/Cytokinesis Using RNA Interference

    Authors: , , , , , , , - Molecular Biology of the Cell 2005 cited by 444

  22. Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling

    Authors: , , , , , , , , , , , - Molecular Cancer Therapeutics 2004 cited by 312

  23. Glutamine: pleiotropic roles in tumor growth and stress resistance

    Authors: , , , - Journal of Molecular Medicine 2011 cited by 178

  24. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002.

    Authors: , , , , , - The EMBO Journal 1996 cited by 723